Netflix profits surge off ads, higher subscription prices
Revenue climbed 16 percent to $11.1 billion in the quarter ended June 30, beating analyst estimates and the company's own guidance, while net profit surged to $3.1 billion.
The company raised its full-year revenue forecast, noting that it expects revenue to be between $44.8 billion and $45.2 billion in 2025, up from a range of $43.5 billion to $44.5 billion.
Netflix highlighted strong performance from its content offers in the quarter, with major hits including the third season of "Squid Game," which drew 122 million views.
It "has already become our sixth biggest season of any series in our history, with just a few weeks of viewing so far," the company said in a statement.
Other standout titles included the third season of "Ginny & Georgia" with 53 million views and "Sirens" with 56 million views.
There was also the animated film "KPop Demon Hunters" with 80 million views, which became "one of our biggest animated films ever" and generated a soundtrack that topped music charts globally.
"Korean content continues to be popular with our audience," the company said, pointing to the continued success of international programming that has become a hallmark of Netflix's global strategy.
Netflix expressed optimism about the second half of 2025, highlighting an upcoming slate that includes the highly anticipated second season of "Wednesday," the final season of "Stranger Things" and new films from major directors including Kathryn Bigelow and Guillermo del Toro.
The company has also announced plans to expand live programming with marquee boxing matches and NFL games, as it continues to diversify its content offerings beyond traditional on-demand entertainment.
Netflix shares have surged more than 40 percent year-to-date as investors have responded positively to the company's shift toward profitability, which saw it crack down on password sharing and turn to ads for more revenue.
The company counted over 300 million subscribers last December, at the end of a particularly successful holiday season, when it gained almost 19 million new subscriptions.
But the company no longer discloses these figures, in order to focus on audience "engagement" metrics (time spent watching content).
In the quarter, Netflix continued to build out its advertising capabilities, saying that it expects to roughly double ads revenue in 2025, though it did not provide specific figures.
The service is forecasting $9 billion in revenues from its ad-based subscriptions by 2030.
"With another robust earnings showing in Q2, Netflix continues a winning streak going back several quarters and cements its place as the leader among streaming services," said Emarketer analyst Paul Verna.
arp/aks
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
27 minutes ago
- Yahoo
GSK shares fall after blood cancer drug likely headed for U.S. rejection
(Reuters) -GSK shares fell more than 6% on Friday after a U.S. FDA advisory panel recommended against approving its blood cancer drug Blenrep, citing earlier concerns over eye-related side effects. The British drugmaker was trying to revive the drug, which was pulled from U.S. markets in 2022 after failing a late-stage study. GSK's renewed application is based on two late-stage trials showing that Blenrep, when used in combination, improved overall survival in patients. The setback from the U.S. FDA advisory vote comes at a time when GSK is focusing on expanding its pipeline to offset declining sales from top drugs and vaccines. The company's shares fell as much as 7% to 1,315 pence, and were the top percentage loser on London's blue-chip FTSE 100 index, which was up 0.2%. The FDA is due to give a formal decision on Blenrep next week, and analysts at Berenberg and JPMorgan said the regulator is unlikely to approve it then. The FDA typically follows the advice of its advisory panels, though it is not bound to do so. "GSK remains confident in the benefit/risk profile of Blenrep and will continue to work closely with the FDA as they complete their review for Blenrep," the company had said in a statement on Thursday. The company has forecast peak annual sales for Blenrep, chemically called belantamab mafodotin, of over 3 billion pounds ($4 billion). The therapy is currently under review for approval in more than 10 countries. Including Friday's losses, GSK shares are down about 2% for the year. ($1 = 0.7449 pounds) Sign in to access your portfolio
Yahoo
27 minutes ago
- Yahoo
Bank7 Corp (BSVN) Q2 2025 Earnings Call Highlights: Strong Loan Growth and High-Quality Asset ...
Net Interest Margin (NIM): Maintained on the higher end of historical range. Efficiency Ratio: Continued benefit from a low efficiency ratio. Loan Growth: Strong loan growth reported. Core Earnings: Experienced nice strong core earnings. Asset Quality: High-quality credit book maintained. Warning! GuruFocus has detected 3 Warning Sign with UAL. Release Date: July 17, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Bank7 Corp (NASDAQ:BSVN) reported one of its best quarters ever, driven by strong loan and deposit growth. The company maintained its Net Interest Margin (NIM) on the higher end of its historical range. Asset quality remains strong, with a high-quality credit book maintained by the credit team. The economic conditions in key markets like Oklahoma and Texas are favorable, supporting business growth. The company has a disciplined approach to mergers and acquisitions, focusing on dynamic markets and common cultures. Negative Points Loan growth can be unpredictable due to lumpy paydowns and asset sales. Deposit costs may increase to fund growth, potentially impacting the NIM. The company faces competitive pricing dynamics in the loan market, which could pressure yields. There is a slight expected increase in expenses over the next quarters. The energy and hospitality portfolios experience significant churn, requiring constant reloading of the customer base. Q & A Highlights Q: How is Bank7 Corp thinking about loan growth momentum for the rest of the year given the strong performance in the first half? A: Jason Estes, President and Chief Credit Officer, mentioned that while loan growth can be lumpy due to paydowns, the deal pipeline looks solid, especially in Oklahoma and Texas. The economic conditions in these areas are favorable, and they expect Q3 to be similar to Q2, although payoffs can be unpredictable. Q: What is the outlook for Net Interest Margin (NIM) given the growth and stable deposit costs? A: Jason Estes noted that while deposit costs may rise slightly to fund growth, the bank focuses on offsetting these with zero-cost transaction accounts. They expect a slight degradation in NIM but aim to remain within historical ranges. Q: Can you provide an update on M&A activity for Bank7 Corp? A: Thomas Travis, President and CEO, stated that while they have come close to deals with signed LOIs, they remain disciplined. They continue to evaluate opportunities, focusing on dynamic markets and common cultures, but it's hard to predict when a deal might occur. Q: What are the competitive pricing dynamics for new loans, and how do they compare to the 7.6% core yield in Q2? A: Jason Estes explained that new loans are slightly lower than the 7.6% yield but the pricing environment is historically normal. There is always pricing pressure, but the market has settled on both the deposit and loan sides. Q: How is Bank7 Corp managing expenses, and what is the outlook for the remainder of the year? A: Kelly Harris, CFO, indicated that Q2 is a solid guide for expenses, with a slight increase expected. They project $2 million in fees, split evenly between oil and gas and core, and $10 million in expenses, with $1 million in oil and gas and $9 million in other expenses. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data
Yahoo
27 minutes ago
- Yahoo
United Airlines Holdings Inc (UAL) Q2 2025 Earnings Call Highlights: Record Revenue and ...
Revenue: Increased 1.7% to a record $15.2 billion in Q2 2025. Consolidated TRASM: Down 4% on a 5.9% increase in capacity. International RASM: Decreased 1%, outperforming domestic RASM, which decreased 7%. Premium Cabin Revenue: Increased 5.6% year-over-year. Cargo Revenue: Up 4% year-over-year on record volumes. Loyalty Revenue: Increased 9% year-over-year. Earnings Per Share (EPS): $3.87, ahead of Wall Street expectations of $3.81. CASM-ex Growth: 2.2% in Q2 2025. Liquidity: Ended Q2 with $18.6 billion, including a $3 billion undrawn revolver. Free Cash Flow: Generated over $1.1 billion in Q2 2025. Debt Reduction: Paid down $1.5 billion of MileagePlus bonds, reducing gross debt by almost $11 billion since COVID peak. Share Buyback: Repurchased $235 million worth of shares at an average price of $66. Net Leverage: Ended Q2 at 2x net leverage. Full Year EPS Guidance: Expected to be between $9 and $11. Free Cash Flow Guidance: Expected to generate over $2 billion for the year. Warning! GuruFocus has detected 3 Warning Sign with UAL. Release Date: July 17, 2025 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points United Airlines Holdings Inc (NASDAQ:UAL) reported a record revenue of $15.2 billion for the second quarter, marking a 1.7% increase. The company experienced a significant improvement in demand, with a double-digit acceleration in business demand and positive inflection in bookings. Operational performance was strong, with United ranking number 2 in on-time departures among the top 8 US carriers. United's international operations outperformed domestic, with positive RASM growth in the Pacific region. The company successfully reduced its gross debt by almost $11 billion since the peak debt level of COVID, strengthening its balance sheet. Negative Points Newark Airport faced significant challenges due to FAA technology outages and runway construction, impacting Q2 margins by approximately 1.2 points. Consolidated TRASM for the quarter was down 4% despite a 5.9% increase in capacity. Demand was weaker than expected in the first half of the year, attributed to high levels of uncertainty for businesses and consumers. The Atlantic region experienced negative RASMs year-over-year, indicating challenges in pushing RASM higher during peak periods. The company anticipates a temporary negative impact on Q3 revenue results due to lingering effects from Newark's issues. Q & A Highlights Q: Can you elaborate on the cost performance and the distribution expense being lower than usual? A: Michael Leskinen, CFO, explained that the cost performance was better than expected, with a 2.2% CASM-ex growth in Q2. He noted that distribution expenses are decreasing as more customers use direct channels, and this trend is expected to continue. There were some temporary factors that reduced costs further in Q2. Q: How has demand changed recently, and are we back to January levels? A: Andrew Nocella, CCO, stated that there has been a 6-point improvement in demand compared to Q2, with a stronger inflection in business traffic. While not fully back to January levels, the recent booking trends are positive, especially with reduced capacity starting in August and September. Q: What factors have led to the revised guidance range for the second half of the year? A: Michael Leskinen, CFO, mentioned that the guidance range of $9 to $11 for the full year includes a conservative approach, accounting for potential unforeseen events. The recent strong booking trends suggest that this range might be conservative if current trends continue. Q: How does United plan to increase its premium product offerings? A: Andrew Nocella, CCO, highlighted that United plans to increase the percentage of premium seats, particularly in the Premium Plus cabin, which has shown strong returns. The introduction of the Polaris Studio suite and the focus on premium capacity are part of this strategy. Q: What is the status of the Starlink implementation on United planes? A: Toby Enqvist, COO, reported that the static interference issue with Starlink on the E175 aircraft has been resolved, and 60 planes are currently equipped with the technology. Larger aircraft will not face the same issue due to their size. For the complete transcript of the earnings call, please refer to the full earnings call transcript. This article first appeared on GuruFocus. Error in retrieving data Sign in to access your portfolio Error in retrieving data
